drugset / Trial / NCT01035437

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

NCT01035437 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study aim is to find out what effects capecitabine, oxaliplatin and radiation therapy following photodynamic therapy have on esophageal cancer.

Timeline

Start
2009-12
Primary completion
2011-01
Completion
2011-02

Outcome

Outcome not reported

Stopped (Enrollment): “no accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a) Unknown 4 mg/m2 —

Indications